Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function
about
Alpha 1-antitrypsin binds to and interferes with functionality of EspB from atypical and typical enteropathogenic Escherichia coli strainsEspF of enteropathogenic Escherichia coli binds sorting nexin 9An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their disseminationAnalysis of host response to bacterial infection using error model based gene expression microarray experiments.Interspecies communication in the gut, from bacterial delivery to host-cell responseAge-Dependent Susceptibility to Enteropathogenic Escherichia coli (EPEC) Infection in MiceTight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coliThe enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunctionComparative analysis of EspF variants in inhibition of Escherichia coli phagocytosis by macrophages and inhibition of E. coli translocation through human- and bovine-derived M cells.The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways.Bundle-forming pilus retraction enhances enteropathogenic Escherichia coli infectivityComparative analysis of locus of enterocyte effacement pathogenicity islands of atypical enteropathogenic Escherichia coli.Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humansInvasiveness as a putative additional virulence mechanism of some atypical Enteropathogenic Escherichia coli strains with different uncommon intimin types.NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection.Modulation of host cytoskeleton function by the enteropathogenic Escherichia coli and Citrobacter rodentium effector protein EspGMouse model of enteropathogenic Escherichia coli infection.EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics.Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier functionE. coli secreted protein F promotes EPEC invasion of intestinal epithelial cells via an SNX9-dependent mechanism.Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.Enteropathogenic Escherichia coli activates ezrin, which participates in disruption of tight junction barrier function.Locus of enterocyte effacement from Citrobacter rodentium: sequence analysis and evidence for horizontal transfer among attaching and effacing pathogens.Bio-physical characteristics of gastrointestinal mucosa of celiac patients: comparison with control subjects and effect of gluten free diet-The ability of an attaching and effacing pathogen to trigger localized actin assembly contributes to virulence by promoting mucosal attachment.A gene from the locus of enterocyte effacement that is required for enteropathogenic Escherichia coli to increase tight-junction permeability encodes a chaperone for EspF.Pathogenesis and evolution of virulence in enteropathogenic and enterohemorrhagic Escherichia coliEnteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VII. Enteropathogenic Escherichia coli: physiological alterations from an extracellular position.Pathogenicity islands in bacterial pathogenesisAnalysis of the function of enteropathogenic Escherichia coli EspB by random mutagenesis.Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium.The N-terminal domain of EspF induces host cell apoptosis after infection with enterohaemorrhagic Escherichia coli O157:H7.Insights into the pathogenesis of enteropathogenic E. coli using an improved intestinal enterocyte modelEscherichia coli as a cause of diarrhea.The pathogen protein EspF(U) hijacks actin polymerization using mimicry and multivalencyFlagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cellsExpression of enteropathogenic Escherichia coli map is significantly different than that of other type III secreted effectors in vivo.In vitro exposure to Escherichia coli decreases ion conductance in the jejunal epithelium of broiler chickensCharacterization of the novel factor paa involved in the early steps of the adhesion mechanism of attaching and effacing Escherichia coli.
P2860
Q24299950-108B790E-39CD-49CC-B8EE-A71F6853DCA1Q24313541-D5847B07-3269-4914-9E53-AE18B5BFD48AQ24678382-F56C1D79-E3A7-4076-B3B2-3A8821B23E15Q24805862-54EE3500-6B06-4FD4-9C28-D56EC57F64D4Q27012975-4590442C-AC6B-4E5F-A5B2-9C565CFC3B24Q27313870-679DA5CF-87C7-4AE3-A8AB-3C27121D3778Q28073886-ED5404F0-FFB0-485D-9AB9-3A05115E8F71Q28474712-A6C6885F-EF4B-4F93-B76A-87AFF433C609Q30010247-60C4476C-3B5F-43D4-8BF6-E11FBFE2D693Q30480560-42A8BB43-CA3B-4A54-843B-634E73E21675Q30502432-873178BE-8397-4E05-928D-4273E36FF6DDQ33208187-767E680C-A752-436C-8B69-C8FF184B99A6Q33444726-24A8E4FF-59E4-44A8-87FD-303DA0A66930Q33484942-61A39E1C-99B1-4A11-9F68-B43B8D695E42Q33733678-FE516BDC-3E0B-49E8-BD6C-6D031E294F7EQ33768868-92117A97-C1F7-47F3-9964-38A62BBB4A88Q33792879-3C1841CA-AA31-43C3-B683-8D88963A3FD4Q33796480-0D54F1F6-843F-4916-AF7D-EAC9952FA8E8Q33899677-D70E1ACD-8CC3-4660-926F-5D93E7451083Q33961475-45721116-E513-448D-8C28-7849F2C2F457Q34001624-4CEF1D06-0FB1-4880-A507-52693DE0724FQ34009023-23F5EA04-4BAF-4A6A-85D9-8667EFC21CC1Q34009383-DB5DFFBC-6E94-4819-9B2E-81DBC90E62D1Q34068869-272AF0FB-983C-4E65-8B4D-2885AA162A36Q34098076-4BEEA31F-7C7C-435B-93F4-2C4DEFA1822AQ34121443-51F7BEAF-C2E0-410C-9CA8-983F8756B14EQ34174695-30DAAA96-756A-4760-AB69-BCB81F1F7F73Q34177961-6FFFE07D-855B-4376-9180-5D86BDD47379Q34283876-DC53E76D-A406-48C0-9B23-88008EE110B6Q34290188-723E7365-C943-4AE4-9E6A-7C5955BDEE76Q34334195-E48E6766-45BD-4578-B2AD-C52727E9A7E2Q34492843-BFBD2B8C-A320-4BA4-AC89-45D5B87B87ABQ34571628-40394D17-02F0-4725-864C-2B6F6829F08BQ34576318-28F51DDE-C373-4F01-A83C-30182FC74EB3Q34619415-E895A952-520F-4AAD-8667-8BEF6A5FAB22Q34799942-E24AA872-8E6B-4C78-90D1-AF7ED2EE508AQ34853145-9ABE4351-8282-4437-96A7-140FED5CDD8AQ34889643-13B972AD-178A-421E-A1D7-80F54A6CDF35Q35122829-36440D92-1A37-4ED2-AE66-A9D5C7639C14Q35165430-87F4CE9C-215D-4497-8DE5-98C0593EDB92
P2860
Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Translocated EspF protein from ...... st intestinal barrier function
@ast
Translocated EspF protein from ...... st intestinal barrier function
@en
Translocated EspF protein from ...... st intestinal barrier function
@nl
type
label
Translocated EspF protein from ...... st intestinal barrier function
@ast
Translocated EspF protein from ...... st intestinal barrier function
@en
Translocated EspF protein from ...... st intestinal barrier function
@nl
prefLabel
Translocated EspF protein from ...... st intestinal barrier function
@ast
Translocated EspF protein from ...... st intestinal barrier function
@en
Translocated EspF protein from ...... st intestinal barrier function
@nl
P2093
P2860
P3181
P356
P1476
Translocated EspF protein from ...... st intestinal barrier function
@en
P2093
A Koutsouris
B P McNamara
C B O'Connell
P2860
P304
P3181
P356
10.1172/JCI11138
P407
P577
2001-03-01T00:00:00Z